ASX Announcement

Remestemcel-L Improves Survival in High-Risk Acute GvHD

Published: 18/10/21, 09:48am (AEST)3 pages
Mesoblast Limited
MSB:ASXHealthcare

Recent MSB Announcements

Price Sensitive only